Aki Miettinen traumapsykoterapia & työnohjaus Oy is a limited company based in Jyväskylä, registered in 2020. In the financial year ending 31.12.2025, revenue was 124 t€ and operating profit 34 t€; equity ratio 91.4 %. Its taxable income in 2024 was 25 t€ and its income taxes 5 071 €. Public buyers bought 27 t€ from it in 2022–2025; the largest buyer is Sosiaali- Ja Terveystoimiala, Helsinki (Helsinki).
Jyväskylä: 31 new companies in 30 days
- Mitapco OyTalonrakentaminen
- Raksagurut OyTalonrakentaminen
- DCH Operations OyVakuutusasiamiesten ja -välittäjien toiminta
Financials
| Key figures | 31.12.2025 | 31.12.2024 |
|---|---|---|
| Revenue | 124 t€ | 118 t€ |
| Revenue change | 4,9 % | – |
| EBITDA | 34 t€ | 25 t€ |
| EBITDA % | 27,6 % | 21,4 % |
| Operating profit | 34 t€ | 25 t€ |
| Operating margin | 27,6 % | 21,4 % |
| Net profit | 27 t€ | 20 t€ |
| Personnel costs | -51 t€ | 57 t€ |
| Equity ratio | 91,4 % | 88,3 % |
| Quick ratio | 11,64 | 8,58 |
| Current ratio | 11,64 | 8,58 |
| Debt to revenue | 6,8 % | 7,5 % |
| Return on equity | 30,6 % | 29,9 % |
| Balance sheet total | 98 t€ | 76 t€ |
| Equity | 89 t€ | 67 t€ |
| Cash and bank | 88 t€ | 66 t€ |
Balance sheet
Income statement and balance sheet
Income statement
| 31.12.2025 | 31.12.2024 | |
|---|---|---|
| Turnover | 124 t€ | 118 t€ |
| Raw materials and services | 736 € | -2 175 € |
| Personnel expenses | 51 t€ | -57 t€ |
| Other operating expenses | 38 t€ | -34 t€ |
| Operating profit (loss) | 34 t€ | 25 t€ |
| Financial income and expenses + (-) | -9 € | 0 € |
| Profit (loss) before appropriations and taxes | 34 t€ | 25 t€ |
| Income taxes | 6 843 € | -5 071 € |
| Profit (loss) for the financial year | 27 t€ | 20 t€ |
Balance sheet
| 31.12.2025 | 31.12.2024 | |
|---|---|---|
| Receivables | 9 530 € | 10 t€ |
| Cash in hand and at banks | 88 t€ | 66 t€ |
| Current assets | 98 t€ | 76 t€ |
| Assets | 98 t€ | 76 t€ |
| Capital and reserves | 89 t€ | 67 t€ |
| Short-term liabilities | 8 394 € | 8 874 € |
| Liabilities | 8 394 € | 8 874 € |
All financial statement items (30)
| 31.12.2025 | 31.12.2024 | |
|---|---|---|
| Turnover | 124 t€ | 118 t€ |
| Raw materials and services | 736 € | -2 175 € |
| Personnel expenses | 51 t€ | -57 t€ |
| Other operating expenses | 38 t€ | -34 t€ |
| Operating profit (loss) | 34 t€ | 25 t€ |
| Financial income and expenses + (-) | -9 € | 0 € |
| Profit (loss) before appropriations and taxes | 34 t€ | 25 t€ |
| Income taxes | 6 843 € | -5 071 € |
| Profit (loss) for the financial year | 27 t€ | 20 t€ |
| Receivables | 9 530 € | 10 t€ |
| Cash in hand and at banks | 88 t€ | 66 t€ |
| Current assets | 98 t€ | 76 t€ |
| Assets | 98 t€ | 76 t€ |
| Capital and reserves | 89 t€ | 67 t€ |
| Short-term liabilities | 8 394 € | 8 874 € |
| Liabilities | 8 394 € | 8 874 € |
| Profit (loss) for the period, equity | 27 t€ | 20 t€ |
| Pension expenses | 8 508 € | -8 083 € |
| Short-term accounts payable | 487 € | 318 € |
| Liabilities | 98 t€ | 76 t€ |
| Other interest and financial income from non-group companies | 9 € | 0 € |
| Short-term accrued expenses and deferred income | 2 613 € | 2 735 € |
| Short-term sales receivables | 8 792 € | 9 694 € |
| Other current liabilities | 5 293 € | 5 821 € |
| Short-term receivables | 9 530 € | 10 t€ |
| Other short-term receivables | 738 € | 486 € |
| Retained earnings | 62 t€ | 47 t€ |
| Purchases during the financial year | 736 € | -2 175 € |
| Other social security expenses | 1 027 € | -587 € |
| Wages and salaries | 41 t€ | -48 t€ |
From financial statements filed digitally (XBRL) with the Finnish Patent and Registration Office; ratios calculated from them. Equity ratio = (equity + accumulated appropriations) / (balance sheet total − advances received).
Taxes
Measured by taxable income, Aki Miettinen traumapsykoterapia & työnohjaus Oy is in the upper half of the industry class other human health activities n.e.c. (1445 companies with taxable income; median 18 t€).
Taxable income is the profit as calculated for taxation, not revenue. Public data from the Finnish Tax Administration; figures for 2025 are published in November 2026.